Shuttle Pharmaceuticals (SHPH) - 2023 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2024 SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (IRS Employer Identification No.) 401 Professional Drive, Suite 260 Gaithersburg, MD 20879 (Address of principal executive offices) (Zip Code) (Exact name of registrant as specified in its charter) Delaware 001-41488 82-5089826 (State or oth ...